GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Purchase Of Business

Artrya (ASX:AYA) Purchase Of Business : A$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Artrya Purchase Of Business?

Artrya's purchase of business for the six months ended in Dec. 2024 was A$0.00 Mil. It means Artrya spent A$0.00 Mil on purchasing business. Artrya's purchase of business for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.00 Mil.

Compared with last quarter (A$0.00 Mil in Jun. 2024 ), Artrya spent the same money on purchasing business in Dec. 2024 (A$0.00 Mil).


Artrya Purchase Of Business Historical Data

The historical data trend for Artrya's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya Purchase Of Business Chart

Artrya Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Purchase Of Business
- - - -

Artrya Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Purchase Of Business Get a 7-Day Free Trial - - - - -

Artrya Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Artrya Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Artrya's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Artrya Business Description

Traded in Other Exchanges
N/A
Address
1257 Hay Street, West Perth, Perth, WA, AUS, 6005
Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines